# India Hydrophobic Interaction Chromatography Market > India Hydrophobic Interaction Chromatography Market Research Report: Size, Share, Trend Analysis By Product and Service (Resins, Columns, Services, Others)– Competitor Industry Analysis and Trends Forecast Till 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.67% - **2024:** $ 41.79 Million - **2025:** $ 45.41 Million - **2035:** $ 104.32 Million - **Key Players:** GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Bio-Rad Laboratories (US), Agilent Technologies (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) **Report ID:** MRFR/MED/54735-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-hydrophobic-interaction-chromatography-market-56501 --- ## Market Summary ## **India Hydrophobic Interaction Chromatography Market Overview** As per MRFR analysis, the India Hydrophobic Interaction Chromatography Market Size was estimated at 6.45 (USD Million) in 2023.The India Hydrophobic Interaction Chromatography Market Industry is expected to grow from 6.94(USD Million) in 2024 to 20.83 (USD Million) by 2035. The India Hydrophobic Interaction Chromatography Market CAGR (growth rate) is expected to be around 10.507% during the forecast period (2025 - 2035). ## **Key India Hydrophobic Interaction Chromatography Market Trends Highlighted** ## **India Hydrophobic Interaction Chromatography Market Drivers** ### **Growing Biopharmaceutical Industry in India** The rapid expansion of the biopharmaceutical industry in India is a prominent driver for the India Hydrophobic Interaction Chromatography Market Industry. Biopharmaceuticals, including monoclonal antibodies and recombinant proteins, are witnessing increasing demand due to rising health issues and a greater focus on research and development.  According to the Department of Pharmaceuticals, the biopharmaceutical sector in India is projected to reach USD 100 billion by 2025, driven by a growing number of biotechnology firms and investments in Research and Development. Established organizations like Biocon and Dr. Reddy's Laboratories are at the forefront of this growth, continuously investing in advanced technologies and processes to enhance productivity. These trends are expected to propel the demand for hydrophobic interaction chromatography techniques, essential for the purification and process optimization of these complex biomolecules. ### **Increase in Regulatory Requirements** The tightening of regulatory frameworks regarding drug safety and efficacy in India is another key driver of the India [Hydrophobic Interaction Chromatography Market](../../../reports/hydrophobic-interaction-chromatography-market-6366) Industry. The Central Drugs Standard Control Organization (CDSCO) has been implementing stricter guidelines for biopharmaceutical manufacturing and quality control.  These regulations push manufacturers to adopt more efficient and reliable purification techniques. For instance, in recent years, the biopharmaceutical industry has witnessed a 30% increase in compliance costs, making advanced separation technologies such as hydrophobic interaction chromatography crucial for meeting quality standards. Leading companies like Serum Institute of India are adapting to these changes by optimizing their purification processes, thus creating a higher demand for hydrophobic interaction chromatography solutions. ### **Rising Research in Protein Therapeutics** The increasing research activities in protein therapeutics are significantly fueling the India Hydrophobic Interaction Chromatography Market Industry. According to the Biotechnology Industry Research Assistance Council (BIRAC), around 20% of research projects in India are focused on protein-based therapeutics.  This surge in research is driven by a deeper understanding of diseases and the potential for targeted treatments. Various universities and research institutions such as the Indian Institute of Technology and Indian Institute of Science are engaged in cutting-edge research that necessitates advanced chromatography techniques for protein purification. As these research initiatives continue to grow, the demand for hydrophobic interaction chromatography will increase, positioning it as a critical component in the development of therapeutic proteins. ### **Technological Advancements in Chromatography** Innovations in chromatography technology are serving as a vital driver for the growth of the India Hydrophobic Interaction Chromatography Market Industry. The advent of high-resolution chromatographic techniques and automated systems has significantly enhanced the efficiency and scalability of purification processes.  According to the India Brand Equity Foundation, there has been a 15% year-on-year growth in the adoption of automation technologies in the laboratory sector.Key players like Agilent Technologies and Merck are continually introducing advanced products that increase productivity and reduce time to market for biopharmaceuticals.  These technological advancements not only optimize existing processes but also expand the application of hydrophobic interaction chromatography in various sectors, including pharmaceuticals, food and beverages, and environmental testing. ## **India Hydrophobic Interaction Chromatography Market Segment Insights****:** ### **Hydrophobic Interaction Chromatography Market Product and Service Insights** The India Hydrophobic Interaction Chromatography Market has been experiencing notable developments within the Product and Service segment, which plays a crucial role in the overall landscape of chromatography solutions. This segment encompasses several vital components, such as resins, columns, services, and other related products, all of which contribute significantly to enhancing the efficiency of separation processes in various applications, particularly in biotechnology and pharmaceutical industries.  Resins are pivotal as they directly influence binding capacity and specificity, making them essential for optimizing the purification of proteins and other biomolecules. Columns, as another integral part of this segment, provide the necessary framework for executing hydrophobic interaction chromatography, and their material construction greatly impacts performance and resolution.  These components are designed to withstand varied operational conditions, thereby catering to a diverse range of applications that require reliability and reproducibility. In recent years, there has been a significant increase in demand for specialized columns that enhance separation quality while minimizing operational costs. Furthermore, the services aspect of the Product and Service segment ensures that users have access to reliable support, including installation, maintenance, and technical assistance.  This support is crucial for laboratories and manufacturing units aiming to achieve optimal performance from their equipment. As India pushes forward in its biopharmaceutical capacity, demand for expertise in chromatography and ongoing innovations in the services sector provides ample opportunities.Among the other products in the segment, offerings such as instrumentation and software for data analysis play an emerging role, helping laboratories to easily monitor and analyze their processes.  The growth trajectory of the Product and Service segment within the India Hydrophobic Interaction Chromatography Market is influenced by several factors, including advancements in technology, increasing investments in research and development (R&D), and a growing emphasis on regulatory compliance in the biopharmaceutical industry.  As the market navigates the evolving landscape of bioprocessing and purification techniques, the continued utilization of quality resins, advanced columns, and comprehensive services will underpin the segment's success. This overall focus not only reflects the demand for better efficiency but also emphasizes the significant value and contribution of each component to achieve higher productivity and yields in biopharmaceutical applications across India. ## **India Hydrophobic Interaction Chromatography Market Key Players and Competitive Insights****:** The India Hydrophobic Interaction Chromatography Market has gained significant momentum due to the increasing demand for biopharmaceuticals and the growing need for effective protein purification methods. Hydrophobic Interaction Chromatography (HIC) is an essential technique employed in various applications, including drug development, vaccine manufacture, and the purification of proteins and other biomolecules.  The market is characterized by the presence of several key players competing on the basis of product offerings, technological advancements, pricing strategies, and customer service.  The competitive landscape is marked by an increasing focus on developing more efficient and user-friendly chromatography solutions, which is driving companies to innovate and enhance their product lines. The regulatory landscape in India, which emphasizes quality and standards, further compels these companies to invest in cutting-edge technologies, thereby intensifying competition in the sector. Lonza Group is a formidable player in the India Hydrophobic Interaction Chromatography Market, recognized for its robust portfolio of biopharmaceutical services and technologies. The company's strengths lie in its advanced manufacturing processes and its ability to provide customized solutions that cater to the unique needs of the biopharmaceutical sector. Lonza's market presence in India has been bolstered by its commitment to quality and compliance with local regulations, positioning it favorably against competitors.  The company’s strong focus on research and development enables it to stay ahead in innovation and address emerging demands in protein purification and bioprocessing in the country. Additionally, Lonza’s strategic partnerships and collaborations with local research institutions further enhance its capabilities and reach within the Indian market. Agilent Technologies also plays a significant role in the India Hydrophobic Interaction Chromatography Market, leveraging its comprehensive suite of analytical instruments and solutions. The company is well-known for its innovative chromatography technologies, which include advanced HIC columns and equipment that are essential for research and industrial applications.  Agilent Technologies has established itself as a trusted provider of high-quality analytical tools, allowing various sectors to achieve superior results in protein separation and purification processes. The company's strengths include its strong market presence backed by extensive distribution networks and customer support services throughout India.  Agilent has also been actively expanding its operations and product offerings in the region through strategic mergers and acquisitions, enabling it to better serve the evolving needs of customers in the Indian market while enhancing its competitive position. ### **Key Companies in the India Hydrophobic Interaction Chromatography Market Include:** - Lonza Group - Agilent Technologies - Sartorius AG - Repligen Corporation - Waters Corporation - Pall Corporation - Fujifilm Diosynth Biotechnologies - BioRad Laboratories - Boehringer Ingelheim - Molecular Devices - Danaher Corporation - [Thermo Fisher Scientific](https://www.thermofisher.com/in/en/home/life-science/bioproduction/poros-chromatography-resin/bioprocess-resins/hydrophobic-interaction-chromatography.html) - Merck Millipore - GE Healthcare - Eppendorf AG ## **India Hydrophobic Interaction Chromatography Market Industry Developments** Recent developments in the India Hydrophobic Interaction Chromatography Market highlight substantial growth potentials and strategic movements among key players. Companies like Lonza Group and Thermo Fisher Scientific have been expanding their portfolios, particularly in biopharmaceutical targeting as demand increases for purification technologies amid expanding drug development in India.  In terms of mergers and acquisitions, Sartorius AG announced the acquisition of a stake in a local biotech firm in July 2023 to bolster its presence in the ever-evolving bioprocessing landscape.  BioRad Laboratories continues to enhance its product offerings in India, focusing on innovative solutions for protein purification that cater to both academic and industrial segments.Market valuation has seen an uptick, with projections suggesting a growth rate of approximately 6% annually, driven by rising investments in biotechnology and pharmaceutical sectors.  This growth trajectory is influenced by Government initiatives promoting research facilities and advanced manufacturing in life sciences, aligning with India's vision for a robust healthcare infrastructure. Such developments signify the increasing focus on refining analytical techniques vital for therapeutic monoclonal antibodies and other biomolecules, reflecting the evolving landscape of bioprocessing in India over the last few years. ## **India Hydrophobic Interaction Chromatography Market Segmentation Insights** ### **Hydrophobic Interaction Chromatography Market Product and Service****Outlook** - Resins - Columns - Services - Others ## Market Drivers ### Expansion of Biotechnology Sector The hydrophobic interaction-chromatography market is significantly influenced by the expansion of the biotechnology sector in India. As biotechnology companies emerge and grow, the need for effective purification methods becomes paramount. Hydrophobic interaction chromatography is recognized for its ability to purify complex biomolecules, making it an essential tool for biotechnology applications. The Indian biotechnology market is anticipated to reach $63 billion by 2025, driven by advancements in genetic engineering, synthetic biology, and other innovative fields. This growth is likely to create a favorable environment for the hydrophobic interaction-chromatography market, as biotechnology firms seek reliable and scalable purification solutions. Furthermore, collaborations between biotechnology companies and research institutions are expected to enhance the development and application of hydrophobic interaction chromatography, further solidifying its role in the biotechnology landscape. ### Increasing Biopharmaceutical Production The hydrophobic interaction-chromatography market is experiencing growth due to the rising production of biopharmaceuticals in India. As the biopharmaceutical sector expands, the demand for effective purification techniques increases. Hydrophobic interaction chromatography is particularly valued for its ability to separate proteins based on their hydrophobic properties, which is crucial in the production of therapeutic proteins and monoclonal antibodies. The Indian biopharmaceutical market is projected to reach $100 billion by 2025, indicating a robust growth trajectory. This surge in biopharmaceutical production necessitates advanced purification methods, thereby driving the hydrophobic interaction-chromatography market. Furthermore, the increasing investment in research and development by pharmaceutical companies in India is likely to enhance the adoption of this technology, as it offers efficient and scalable solutions for protein purification. ### Growing Focus on Bioprocess Optimization The hydrophobic interaction-chromatography market is poised for growth as industries increasingly focus on bioprocess optimization. Companies are striving to enhance the efficiency and yield of biopharmaceutical production processes, which necessitates the adoption of advanced purification techniques. Hydrophobic interaction chromatography offers a robust solution for separating and purifying proteins, thereby improving overall process efficiency. The Indian biopharmaceutical industry is projected to grow at a CAGR of 22% from 2020 to 2025, indicating a strong demand for optimized bioprocessing solutions. As organizations seek to reduce production costs and improve product quality, the hydrophobic interaction-chromatography market is likely to see increased adoption. Additionally, the integration of automation and process analytical technologies in bioprocessing is expected to further drive the demand for efficient purification methods, including hydrophobic interaction chromatography. ### Regulatory Support for Biopharmaceuticals The hydrophobic interaction-chromatography market is positively impacted by the increasing regulatory support for biopharmaceuticals in India. The government has been implementing policies to streamline the approval process for biopharmaceutical products, which encourages companies to invest in research and development. As regulatory frameworks evolve, there is a growing emphasis on the quality and safety of biopharmaceuticals, necessitating the use of advanced purification techniques. Hydrophobic interaction chromatography is recognized for its effectiveness in ensuring the purity of therapeutic proteins, aligning with regulatory requirements. The Indian biopharmaceutical market is expected to witness substantial growth, with regulatory support playing a crucial role in facilitating this expansion. Consequently, the demand for hydrophobic interaction-chromatography is likely to increase as companies seek to comply with stringent regulatory standards while ensuring the quality of their products. ### Rising Research Activities in Life Sciences The hydrophobic interaction-chromatography market is benefiting from the surge in research activities within India's life sciences sector. With a growing emphasis on drug discovery and development, academic institutions and research organizations are increasingly utilizing advanced chromatographic techniques. Hydrophobic interaction chromatography is particularly favored for its efficiency in purifying biomolecules, which is essential for various research applications. The Indian government has been actively promoting research initiatives, leading to an increase in funding and collaboration between academia and industry. This trend is expected to bolster the hydrophobic interaction-chromatography market, as researchers seek reliable and effective methods for protein purification. Moreover, the rise in biotechnology startups in India further contributes to the demand for innovative purification technologies, positioning hydrophobic interaction chromatography as a key player in the evolving landscape of life sciences research. ## Future Outlook The [Hydrophobic Interaction Chromatography Market](https://www.marketresearchfuture.com/reports/hydrophobic-interaction-chromatography-market-6366) is projected to grow at 8.67% CAGR from 2025 to 2035, driven by increasing biopharmaceutical demand and technological advancements. **New opportunities:** - Development of customized resin solutions for specific applications. - Expansion of training programs for chromatography technicians. - Investment in automated chromatography systems for enhanced efficiency. By 2035, the market is expected to achieve substantial growth, reflecting robust demand and innovation. ## Segment Insights ### By Product and Service: Resins (Largest) vs. Buffers (Fastest-Growing) In the India hydrophobic interaction-chromatography market, the segment distribution is characterized by significant shares held by various product categories. Resins dominate the segment due to their critical role in the purification process, capturing a substantial market share. Buffers follow closely, with their essential functionality for maintaining pH levels contributing to their prominence in the market. Columns also play a vital role, though they hold a smaller yet essential niche for specific applications. Growth trends in this segment indicate a shift towards enhanced functionality and efficiency in purification processes. The rising demand for biopharmaceuticals drives the need for innovative solutions such as specialty resins and advanced buffering systems. As a result, the buffers segment is emerging as the fastest-growing category, driven by advancements in formulation technologies and increased end-user adoption in laboratories and industrial settings. Resins (Dominant) vs. Buffers (Emerging) Resins are the dominant products in the hydrophobic interaction-chromatography segment, primarily due to their robust performance in separating biomolecules effectively. Their formulation is designed to facilitate high binding capacities while maintaining stability across various process conditions. Conversely, buffers are gaining momentum as emerging solutions, essential for optimizing the separation process and ensuring the reliability of outcomes. As analytical techniques evolve, the demand for innovative buffering agents is surging, catering to the diverse needs of laboratories looking for precision in chromatographic applications. Together, these product categories highlight the dynamic nature of the India hydrophobic interaction-chromatography market, with resins leading and buffers rapidly evolving to meet increasing market demands. ### By Sample Type: Monoclonal Antibodies (Largest) vs. Vaccines (Fastest-Growing) In the India hydrophobic interaction-chromatography market, the sample type segment is primarily dominated by monoclonal antibodies, which command a significant portion of the market share. Following this are vaccines, which are also experiencing notable attention due to their increasing application in therapeutic developments. The others category accounts for the remaining share, highlighting the diverse needs within the industry. This distribution emphasizes the importance of monoclonal antibodies in research and clinical settings, validating their leading position in the market. Growth trends indicate that monoclonal antibodies will continue to be a pivotal force due to their extensive applications in drug development, while vaccines are rapidly gaining traction as a result of growing public health initiatives. Various drivers such as increased investment in biopharmaceuticals, technological advancements in production processes, and the rising prevalence of chronic diseases are contributing to the expansion of these segments. As a result, both categories are expected to witness a healthy growth trajectory in the foreseeable future. Monoclonal Antibodies (Dominant) vs. Vaccines (Emerging) Monoclonal antibodies have established themselves as the dominant force in the India hydrophobic interaction-chromatography market due to their specificity and efficacy in targeting various diseases. They are heavily utilized in therapeutic applications, which reinforces their stronghold. On the other hand, vaccines are considered an emerging segment, rapidly gaining ground due to increased investments and focus on immunization programs. Their ability to adapt to new pathogens and innovations in vaccine delivery systems contributes to their increasing demand. The interplay between these two segments reveals a dynamic market landscape, with monoclonal antibodies leading while vaccines capitalize on innovative advancements and growing healthcare needs. ### By End-User: Pharmaceutical & Biopharmaceutical Companies (Largest) vs. Contract Research Organizations & Contract Manufacturing Organizations (Fastest-Growing) The India hydrophobic interaction-chromatography market is predominantly driven by the pharmaceutical & biopharmaceutical companies, which hold the largest market share owing to their extensive research and development activities. These companies leverage advanced chromatographic techniques for the purification and characterization of biologics, contributing significantly to the overall growth of the market. In contrast, contract research organizations (CROs) and contract manufacturing organizations (CMOs) are rapidly expanding their market presence, catering to the rising demand for outsourced services in drug development and manufacturing. As the biopharmaceutical sector continues to innovate, the need for effective purification methods such as hydrophobic interaction chromatography is increasing. The growth of CROs and CMOs can be attributed to the overall trend towards outsourcing in the biopharmaceutical industry, allowing drug developers to focus on core competencies while minimizing costs. Moreover, research and academic institutes are also playing a crucial role by conducting pivotal research, further driving advancements in this segment. Pharmaceutical & Biopharmaceutical Companies (Dominant) vs. Contract Research Organizations & Contract Manufacturing Organizations (Emerging) Pharmaceutical & biopharmaceutical companies are the dominant players in the hydrophobic interaction-chromatography market due to their established infrastructures and significant investments in R&D. They utilize this technique for the efficient purification of therapeutic proteins and monoclonal antibodies, ensuring product quality and efficacy. On the other hand, contract research organizations and contract manufacturing organizations are emerging by offering flexible, cost-effective solutions that cater to the growing needs of the pharmaceutical industry. Their agility in adapting to new technologies and methodologies enables them to provide specialized services that complement the capabilities of larger companies, making them essential partners in the drug development process. ## Competitive Benchmarking The hydrophobic interaction-chromatography market in India is characterized by a dynamic competitive landscape, driven by increasing demand for biopharmaceuticals and advancements in protein purification technologies. Key players such as GE Healthcare (US), Thermo Fisher Scientific (US), and Merck KGaA (DE) are strategically positioned to leverage these growth drivers. GE Healthcare (US) focuses on innovation in bioprocessing solutions, while Thermo Fisher Scientific (US) emphasizes digital transformation and integrated workflows. Merck KGaA (DE) is enhancing its operational focus on sustainability and efficiency in manufacturing processes. Collectively, these strategies contribute to a competitive environment that is increasingly centered around technological advancements and customer-centric solutions.In terms of business tactics, companies are localizing manufacturing to reduce costs and enhance supply chain efficiency. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set industry standards and drive innovation. This competitive structure fosters an environment where smaller firms may struggle to keep pace with the rapid advancements and operational efficiencies established by larger entities. In October Thermo Fisher Scientific (US) announced the launch of a new line of hydrophobic interaction chromatography columns designed to improve protein yield and purity. This strategic move is likely to enhance their product portfolio and strengthen their market position, as it addresses the growing need for efficient purification methods in biopharmaceutical production. The introduction of these advanced columns may also attract new customers seeking to optimize their workflows. In September Merck KGaA (DE) expanded its manufacturing capabilities in India by investing €50 million in a new facility dedicated to bioprocessing technologies. This investment underscores the company's commitment to meeting the rising demand for biopharmaceuticals in the region. By enhancing local production capabilities, Merck KGaA (DE) is positioned to respond more effectively to customer needs while also reducing lead times and transportation costs. In August GE Healthcare (US) entered into a strategic partnership with a leading Indian biopharmaceutical company to co-develop innovative purification solutions. This collaboration is indicative of a broader trend towards strategic alliances that enhance technological capabilities and market reach. By leveraging each other's strengths, both companies are likely to accelerate the development of cutting-edge solutions tailored to the unique challenges of the Indian market. As of November current competitive trends in the hydrophobic interaction-chromatography market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence in purification processes. Strategic alliances are increasingly shaping the landscape, allowing companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine market dynamics, compelling companies to invest in R&D and sustainable practices to maintain a competitive edge. ## Recent News & Developments Recent developments in the India Hydrophobic Interaction Chromatography Market highlight substantial growth potentials and strategic movements among key players. Companies like Lonza Group and Thermo Fisher Scientific have been expanding their portfolios, particularly in biopharmaceutical targeting as demand increases for purification technologies amid expanding drug development in India.  In terms of mergers and acquisitions, Sartorius AG announced the acquisition of a stake in a local biotech firm in July 2023 to bolster its presence in the ever-evolving bioprocessing landscape.  BioRad Laboratories continues to enhance its product offerings in India, focusing on innovative solutions for protein purification that cater to both academic and industrial segments.Market valuation has seen an uptick, with projections suggesting a growth rate of approximately 6% annually, driven by rising investments in biotechnology and pharmaceutical sectors.  This growth trajectory is influenced by Government initiatives promoting research facilities and advanced manufacturing in life sciences, aligning with India's vision for a robust healthcare infrastructure. Such developments signify the increasing focus on refining analytical techniques vital for therapeutic monoclonal antibodies and other biomolecules, reflecting the evolving landscape of bioprocessing in India over the last few years. ## Report Scope | MARKET SIZE 2024 | 41.79(USD Million) | | --- | --- | | MARKET SIZE 2025 | 45.41(USD Million) | | MARKET SIZE 2035 | 104.32(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.67% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Bio-Rad Laboratories (US), Agilent Technologies (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) | | Segments Covered | Product and Service, Sample Type, End-User | | Key Market Opportunities | Advancements in biopharmaceuticals drive demand for innovative solutions in the hydrophobic interaction-chromatography market. | | Key Market Dynamics | Rising demand for biopharmaceuticals drives innovation in hydrophobic interaction-chromatography technologies and applications. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the hydrophobic interaction-chromatography market in India as of 2024?** A: The market valuation was $41.79 Million in 2024. **Q: What is the projected market size for hydrophobic interaction-chromatography in India by 2035?** A: The projected valuation for 2035 is $104.32 Million. **Q: What is the expected CAGR for the hydrophobic interaction-chromatography market in India during the forecast period 2025 - 2035?** A: The expected CAGR during this period is 8.67%. **Q: Which companies are the key players in the hydrophobic interaction-chromatography market in India?** A: Key players include GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Agilent Technologies, Waters Corporation, Pall Corporation, and Repligen Corporation. **Q: What are the main product segments in the hydrophobic interaction-chromatography market in India?** A: Main product segments include Resins, Columns, Buffers, and Other Products and Services. **Q: How did the revenue from Columns compare to that from Resins in the hydrophobic interaction-chromatography market in 2024?** A: In 2024, revenue from Columns was $15.0 Million, while Resins generated $10.0 Million. **Q: What sample types are primarily analyzed using hydrophobic interaction-chromatography in India?** A: The primary sample types include Monoclonal Antibodies, Vaccines, and Others. **Q: What was the revenue generated from Monoclonal Antibodies in the hydrophobic interaction-chromatography market in 2024?** A: Revenue from Monoclonal Antibodies was $15.0 Million in 2024. **Q: Which end-user segments are driving the hydrophobic interaction-chromatography market in India?** A: End-user segments include Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations, and Research & Academic Institutes. **Q: What was the revenue from Pharmaceutical & Biopharmaceutical Companies in the hydrophobic interaction-chromatography market in 2024?** A: In 2024, revenue from Pharmaceutical & Biopharmaceutical Companies was $16.72 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-hydrophobic-interaction-chromatography-market-56501*